AMLX AMYLYX PHARMACEUTICALS INC
2026Q1 · CUSIP 03237H101 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
170
Δ holders QoQ
-9
Breadth percentile
Top 85%
Whale holders
91
Δ whales
0
Inst. holding value
$1.6B
New positions
28
Closed positions
37
Price momentum (1Q)
-9.0%
Put / Call
5/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 7% | +0.3% | -2.6% |
| 2025Q1 | Top 19% | +45.9% | +160.8% |
| 2023Q3 | Top 11% | +22.9% | -84.8% |
| 2023Q1 | Top 14% | -27.3% | -52.9% |
| 2022Q4 | Top 9% | -23.8% | -42.6% |
| 2022Q3 | Top 7% | +6.4% | -23.5% |
Options Sentiment
Put holders
5
QoQ: 0
Call holders
6
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.48
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)